Enhanced Drug Delivery for Cardiac Microvascular Obstruction with an Occlusion-Infusion-Catheter.

Authors:
Rösch Y; Eggenberger D; Kuster Y; Widmer L; Frey S and 4 more

Journal:
Ann Biomed Eng

Publication Year: 2023

DOI:
10.1007/s10439-023-03142-z

PMCID:
PMC10172228

PMID:
36681747

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Biomed Eng

Abbreviation: Ann Biomed Eng

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Parameterisation and Prediction of Intra-canal Cochlear Structures.
Thiselton J; Hanekom T. (2024) - Transparency Score: 3/6
3D-Ultrasound Based Mechanical and Geometrical Analysis of Abdominal Aortic Aneurysms and Relations…
Maas EJ; Nievergeld AHM; Fonken JHC and 3 more (2023) - Transparency Score: 3/6
A Millifluidic Chamber for Controlled Shear Stress Testing: Application to Microbial Cultures.
Biagini F; Botte E; Calvigioni M and 5 more (2023) - Transparency Score: 3/6
Analysis of In Vivo Skin Anisotropy Using Elastic Wave Measurements and Bayesian Modelling.
Nagle M; Price S; Trotta A and 3 more (2023) - Transparency Score: 3/6
An Experimental Cold Gas Cannon for the Study of Porcine Lung Contusion and Behind Armor Blunt Trau…
Karlsson T; Olsson LG; Gustavsson J and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest SF and RSS own stock and/or stock options in CorFlow Therapeutics AG. SF is an employee of CorFlow Therapeutics AG. SF, RSS, CN and DO have a pending patent application for a microfluidic coronary circulation model. The work of YR was partially funded by CorFlow Therapeutics AG. LW declares no conflicts of interest."

Evidence found in paper:

"Funding Open access funding provided by University of Bern."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025